These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6936727)

  • 1. Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia.
    Baron M; Levitt M; Perlman R
    Psychiatry Res; 1980 Dec; 3(3):329-35. PubMed ID: 6936727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity.
    Buchsbaum MS; Coursey RD; Murphy DL
    Science; 1976 Oct; 194(4262):339-41. PubMed ID: 968488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia.
    Baron M; Levitt M; Gruen R; Kane J; Asnis L
    Am J Psychiatry; 1984 Jul; 141(7):836-42. PubMed ID: 6731631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parents of high risk subjects defined by levels of monoamine oxidase activity.
    Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL
    Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicide attempts, platelet monoamine oxidase and the average evoked response.
    Buchsbaum MS; Haier RJ; Murphy DL
    Acta Psychiatr Scand; 1977 Jul; 56(1):69-79. PubMed ID: 331876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO activity and evoked potentials in the identification of subjects biologically at risk for psychiatric disorders.
    Coursey RD; Buchsbaum MS; Murphy DL
    Br J Psychiatry; 1979 Apr; 134():372-81. PubMed ID: 444787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole blood serotonin and platelet MAO in children with schizophrenia and major depressive disorder.
    Rogeness GA; Mitchell EL; Custer GJ; Harris WR
    Biol Psychiatry; 1985 Mar; 20(3):270-5. PubMed ID: 3978162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders.
    Young JG; Cohen DJ; Waldo MC; Feiz R; Roth JA
    Schizophr Bull; 1980; 6(2):324-33. PubMed ID: 7375865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.
    Whitfield JB; Pang D; Bucholz KK; Madden PA; Heath AC; Statham DJ; Martin NG
    Psychol Med; 2000 Mar; 30(2):443-54. PubMed ID: 10824664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential.
    Haier RJ; Buchsbaum MS; Murphy DL; Gottesman II; Coursey RD
    Arch Gen Psychiatry; 1980 Mar; 37(3):340-5. PubMed ID: 7362421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet MAO activity and psychosis proneness in college students.
    Yehuda R; Edell WS; Meyer JS
    Psychiatry Res; 1987 Feb; 20(2):129-42. PubMed ID: 3575559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality disorders according to DSM-III-R and thrombocyte monoamine oxidase activity in type 1 and type 2 alcoholics.
    Hallman J; von Knorring L; Oreland L
    J Stud Alcohol; 1996 Mar; 57(2):155-61. PubMed ID: 8683964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced platelet MAO activity and vulnerability to psychiatric disorders.
    Pandey GN; Dorus E; Shaughnessy R; Gaviria M; Val E; Davis JM
    Psychiatry Res; 1980 Jul; 2(3):315-21. PubMed ID: 6932071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity as a biological marker in a Swedish forensic psychiatric population.
    Stålenheim EG; von Knorring L; Oreland L
    Psychiatry Res; 1997 Mar; 69(2-3):79-87. PubMed ID: 9109175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity.
    von Knorring L; Perris C; Oreland L; Eisemann M; Holmgren S; Perris H
    Psychiatry Res; 1985 Aug; 15(4):271-9. PubMed ID: 3865245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO activity: relationships to clinical and psychometric variables.
    Adler SA; Gottesman II; Orsulak PJ; Kizuka PP; Schildkraut JJ
    Schizophr Bull; 1980; 6(2):226-31. PubMed ID: 7375854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisited.
    Propping P; Rey ER; Friedl W; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1981; 230(3):209-19. PubMed ID: 7295010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase in families of chronic schizophrenics.
    Berrettini WH; Benfield TC; Schmidt AO; Ladman RK; Vogel WH
    Schizophr Bull; 1980; 6(2):235-7. PubMed ID: 7375856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet MAO-B, personality, and psychopathology.
    Ruchkin VV; Koposov RA; af Klinteberg B; Oreland L; Grigorenko EL
    J Abnorm Psychol; 2005 Aug; 114(3):477-82. PubMed ID: 16117585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.